Lornoxicam dispersible tablets
Function and Efficacy
Lornoxicam is a non-steroidal anti-inflammatory analgesic and a thiazide derivative. It inhibits the synthesis of prostaglandins by inhibiting the activity of cyclooxygenase (COX), and has strong analgesic and anti-inflammatory effects. Animal in vivo safety studies have shown that the toxicity characteristics of this product are consistent with its inhibitory effect on cyclooxygenase, and the digestive tract and kidneys are the most sensitive organs to toxicity.
Ingredients
The main ingredient of this product is lornoxicam. The auxiliary materials are: sodium lauryl sulfate, microcrystalline cellulose, aspartame, citric acid, sodium carboxymethyl starch, 4% PVP-K30, magnesium stearate, and micro-powder silica gel.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LornoxicamIngredients |
Nonsteroidal anti-inflammatory analgesics inhibit prostaglandin synthesis by inhibiting the activity of cyclooxygenase (COX) and have strong analgesic and anti-inflammatory effects More |
70374-39-9 | 10 |
Appearance
This product is a yellow tablet.
Indication
Acute moderate postoperative pain and pain associated with acute lumbar and sciatica.
Usage and Dosage
1. Acute mild or moderate pain: daily dose is 8-16 mg (1-2 tablets); for single use, take 1 or 2 tablets. For repeated use, the maximum daily dose is 16 mg. It is best to take 1 tablet twice a day. 2. Joint pain and inflammation caused by rheumatic diseases: daily dose is 16 mg, 1 tablet each time, 2 times a day is recommended. The maximum daily dose should not exceed 16 mg (2 tablets). Take as directed by your doctor.
Adverse Reactions
The most common adverse reactions were dizziness, headache and gastrointestinal reactions.
Precautions
It is contraindicated for patients with peptic ulcer and hemorrhagic diseases, severe liver and kidney dysfunction, renal failure, significantly decreased platelets, and allergic to the ingredients of this product. It is contraindicated for pregnant and lactating women.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
seal.
Packaging Specification
8mg
Validity Period
36 months
Manufacturer
Changchun Haiwang Biological Pharmaceutical Co., Ltd.
-
Founded in:
1995-01-25 -
Address:
No. 833, Huoju Road, Qianjin Street, High-tech Development Zone, Changchun City, Jilin Province; -
Tax NO.:
91220101243880532N -
Registered Funds:
20 million yuan -
Website:
-
Email: